These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2931797)

  • 1. The immunodeficiency of bone marrow-transplanted patients. The effect of patient lymphocytes on the response of donor lymphocytes to mitogens and allogeneic cells.
    Odum N; Hofmann B; Platz P; Ryder LP; Langhoff E; Jakobsen BK; Svejgaard A; Jacobsen N
    Scand J Immunol; 1985 Sep; 22(3):259-66. PubMed ID: 2931797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunodeficiency of bone marrow-transplanted patients. II. CD8-related suppression by patient lymphocytes of the response of donor lymphocytes to mitogens, antigens, and allogeneic cells.
    Odum N; Hofmann B; Jacobsen N; Langhoff E; Møller J; Platz P; Ryder LP; Svejgaard A
    Scand J Immunol; 1987 Sep; 26(3):247-53. PubMed ID: 2958929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow transplantation with T-cell-depleted grafts. II. Reconstitution of immunohemopoietic functions in lethally irradiated mice transplanted with unseparated or T-cell-depleted bone marrow grafts disparate at minor histocompatibility antigens.
    Leshem B; Tsuberi BZ; Lebendiker Z; Anafi-Ayalon M; Shalit M; Weiss L; Slavin S; Kedar E
    Transplantation; 1987 Jun; 43(6):814-7. PubMed ID: 2954282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proliferation of peripheral lymphocytes to interleukin-2 and interleukin-4 after marrow transplantation.
    Klingemann HG; Kohn FR; Phillips GL
    Eur Cytokine Netw; 1991; 2(2):131-6. PubMed ID: 1813016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-2 production and response to interleukin-2 by peripheral blood mononuclear cells from patients after bone marrow transplantation: II. Patients receiving soybean lectin-separated and T cell-depleted bone marrow.
    Welte K; Keever CA; Levick J; Bonilla MA; Merluzzi VJ; Mertelsmann R; Evans R; O'Reilly RJ
    Blood; 1987 Nov; 70(5):1595-603. PubMed ID: 3311208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-lasting deficit of functional T cell precursors in human bone marrow transplant recipients revealed by limiting dilution methods.
    Rozans MK; Smith BR; Burakoff SJ; Miller RA
    J Immunol; 1986 Jun; 136(11):4040-8. PubMed ID: 2939139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressor T cells in allogeneic bone marrow chimeras.
    Leshem B; Lebendiker Z; Weiss L; Slavin S; Kedar E
    Bone Marrow Transplant; 1987 Aug; 2(2):123-32. PubMed ID: 2901877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary characterization of functional residual host-type T lymphocytes following conditioning for allogeneic HLA-matched bone marrow transplantation (BMT).
    Kedar E; Or R; Naparstek E; Zeira E; Slavin S
    Bone Marrow Transplant; 1988 Mar; 3(2):129-40. PubMed ID: 3048477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-7 drives donor T cell proliferation and can costimulate cytokine secretion after MHC-matched allogeneic bone marrow transplantation.
    Levy RB; Jones M; Hamilton BL; Paupe J; Horowitz T; Riley R
    J Immunol; 1995 Jan; 154(1):106-15. PubMed ID: 7995931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of the spleen on compartmental levels and distribution of donor progenitor cells after syngeneic and allogeneic bone marrow transplants.
    Shatry AM; Jones M; Levy RB
    Stem Cells Dev; 2004 Feb; 13(1):51-62. PubMed ID: 15068693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-tolerance to host and donor following HLA-mismatched bone marrow transplantation.
    De Villartay JP; Griscelli C; Fischer A
    Eur J Immunol; 1986 Feb; 16(2):117-22. PubMed ID: 3514234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunodeficiency after allogeneic bone marrow transplantation in man. Effect of phorbol ester (phorbol myristate acetate) and calcium ionophore (A23187) in vitro.
    Møller J; Hofmann B; Langhoff E; Damgård Jacobsen K; Odum N; Dickmeiss E; Ryder LP; Thastrup O; Scharff O; Foder B
    Scand J Immunol; 1989 Oct; 30(4):441-7. PubMed ID: 2510289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of selective T cell depletion of host and/or donor bone marrow on lymphopoietic repopulation, tolerance, and graft-vs-host disease in mixed allogeneic chimeras (B10 + B10.D2----B10).
    Ildstad ST; Wren SM; Bluestone JA; Barbieri SA; Stephany D; Sachs DH
    J Immunol; 1986 Jan; 136(1):28-33. PubMed ID: 2933464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA
    Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative outcomes of T-cell-depleted and non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: impact of donor lymphocyte infusion.
    Sehn LH; Alyea EP; Weller E; Canning C; Lee S; Ritz J; Antin JH; Soiffer RJ
    J Clin Oncol; 1999 Feb; 17(2):561-8. PubMed ID: 10080600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified responses to recipient and donor B cells by genetically donor T cells from human haploidentical bone marrow chimeras.
    Schiff SE; Buckley RH
    J Immunol; 1987 Apr; 138(7):2088-94. PubMed ID: 2881966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological studies in the acquired immunodeficiency syndrome. II. Active suppression or intrinsic defect--investigated by mixing AIDS cells with HLA-DR identical normal cells.
    Hofmann B; Odum N; Jakobsen BK; Platz P; Ryder LP; Nielsen JO; Gerstoft J; Svejgaard A
    Scand J Immunol; 1986 Jun; 23(6):669-78. PubMed ID: 2940675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibiton of IL 2 production after human allogeneic bone marrow transplantation.
    Azogui O; Gluckman E; Fradelizi D
    J Immunol; 1983 Sep; 131(3):1205-8. PubMed ID: 6224851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of circulating suppressor T lymphocytes in bone marrow transplant recipients.
    Gebel HM; Kaizer H; Landay AL
    Transplantation; 1987 Feb; 43(2):258-63. PubMed ID: 2949405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete donor T cell chimerism is accomplished in patients transplanted with bone marrow grafts containing a fixed low number of T cells.
    Verdonck LF; van Blokland WT; Bosboom-Kalsbeek EK; van Heugten HG; Tilanus MG; de Weger RA
    Bone Marrow Transplant; 1996 Aug; 18(2):389-95. PubMed ID: 8864451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.